glp-1 agonist and heart failure JCI GLP-1 Receptor Agonists for the

Between-study heterogeneity was moderate (I = 65%, Q = 5.39, p = 0.068

According to the websites of these drugs, there are warnings that there may be dose-dependent and treatment duration-dependent risk for C cell tumors at clinically relevant exposures. This has not been studied in humans and, thus far, there are no reports of these findings

Publishers Note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

There was a case reported of a 46-year-old man with increasing visual deterioration and difficulty with night driving over three months, during which he had been drinking a gallon of tonic water a day

What do you think is the most underestimated Black Box Warning that every healthcare professional should remember